Payal Kapur

19PUBLICATIONS
119CO-AUTHORS
Cancer cell biologyMolecular targetsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Radiation therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

|Jul 17, 2026
A single chromosome 3p break initiates clear cell renal cell carcinoma evolution.

|Jul 03, 2026
A Visually Interpretable Histopathology-Based Immune Model Predicts T-effector Biology and Response to Immune checkpoint inhibition in Clear Cell Renal Cell Carcinoma Clinical Trial and Contemporary Real-World Datasets.

|Dec 03, 2025
Radiologic, Pathologic, and Deep Learning Predictors of Response to Immune Checkpoint Blockade in Renal Cell Carcinoma Patients Undergoing Post-Treatment Nephrectomy.

Payal Kapur, Alana Christie, Vipul Jarmale

|Oct 09, 2025
HIF-2-Dependent Regulation of PTHrP and Paraneoplastic Hypercalcemia in Aggressive Clear-Cell Renal Cell Carcinoma.

Arijit Mal, Bingqing Xie, Zane Gray

|Mar 18, 2025
In Pursuit of KI-RADS: Toward a Single, Evidence-based Imaging Classification of Renal Masses.

Stuart G Silverman, Ivan Pedrosa, Nicola Schieda

|Mar 18, 2025
Histopathology based AI model predicts anti-angiogenic therapy response in renal cancer clinical trial.

Jay Jasti, Hua Zhong, Vandana Panwar

Pageof 4

Frequent Collaborators

11 joint publications

James Brugarolas

4 joint publications

Alana Christie

4 joint publications

Ivan Pedrosa

4 joint publications

Vanina Toffessi-Tcheuyap